← FDA Drug Approvals (Drugs@FDA)

REVLIMID

NDA · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2005-12-27

Drug application

FDA Application #

NDA021880

Application type

New Drug Application

Brand name

REVLIMID

Generic name

LENALIDOMIDE

Active ingredients

LENALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL MYERS SQUIBB

Manufacturer

Celgene Corporation

First approval

2005-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown